contrast agents with the highest relaxivity for magnetic resonance imaging (MRI) and NIR-II cancer therapy agents. Combining these characteristics, we propose an MRI-guided approach to precision cancer therapy that offers a pathway for the rapid advancement of nanomedicine.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: